Categories: All postsAnalysts

Cortex Business Solutions gets price target raise to $7.00 at Beacon Securities

Following a quarter that bested his expectations, Beacon Securities analyst Gabriel Leung has raised his price target on Cortex Business Solutions (Cortex Business Solutions Stock Quote, Chart, News: TSXV:CBX).

On December 5, Cortex reported its Q1, 2018 results. The company earned $286,464 on revenue of $3.2-million, a topline that was up 31 per cent over the same period last year.

“As represented by our successful quarter-over-quarter growth of 31 per cent in top-line revenue and a relatively flat cost line, Cortex’s push to grow revenue and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, non-recurring charges, and share-based payments) (1) with our current team is working. We will continue to focus on these metrics and to improve them to grow our business,” said CEO Joel Leetzow. “With substantial milestones achieved in our product, a repeatable business model, the implementation of a proven sales strategy, combined with the delivery of set-up and integration services, Cortex is positioned to sustain and build on results from this quarter and achieve continued growth and value for its stakeholders.”

Leung notes that Cortex’s revenue and EBITDA numbers of $3.2-million and $654,000, respectively, bested his expectation of $3.0-million and $202,000.

The analyst says this was a very positive quarter, considering the literal headwinds the company faced.

“In our opinion, the fiscal Q1 results were a very positive data point particularly in light of the headwinds stemming from Hurricane Harvey,” Leung says. “More importantly, we believe the operating leverage thesis is playing out as evidenced by the strong q/q improvement in EBITDA margins, which we believe could continue to improve as revenue growth accelerates.”

In a research update to clients today, Leung maintained his “Buy” rating, but raised his one-year price target on Cortex from $6.25 to $7.00, implying a return of 63 per cent at the time of publication.

Leung thinks Cortex will generate EBITDA of $2.5-million on revenue of $13.0-million in fiscal 2018. He expects those numbers will improve to EBITDA of $3.8-million on a topline of $15.4-million the following year.

More Cantech Analysts

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: cbx
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Chorus Aviation price target trimmed at CIBC

Following first quarter results, CIBC analyst Kevin Chiang has lowered his price target on Chorus Aviation (Chorus Aviation Stock Quote,… [Read More]

5 hours ago

Is Magellan Aerospace stock a buy?

Its first quarter results are in the books and Paradigm Capital analyst J Marvin Wolff thinks there is money to… [Read More]

1 day ago

Phunware is undervalued, Roth says

Ahead of the company's first quarter results, Roth MKM analyst Darren Aftahi thinks there is money to be made on… [Read More]

1 day ago

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

1 day ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

2 days ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

2 days ago